217 results on '"Ding, Pei-Rong"'
Search Results
2. The effects of oxaliplatin-based adjuvant chemotherapy in high-risk stage II colon cancer with mismatch repair-deficient: a retrospective study
3. Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A randomized controlled trial
4. Neoadjuvant camrelizumab plus apatinib for locally advanced microsatellite instability-high or mismatch repair-deficient colorectal cancer (NEOCAP): a single-arm, open-label, phase 2 study
5. Efficacy of PD-1 inhibitors for colorectal cancer and polyps in Lynch syndrome patients
6. Neoadjuvant Chemotherapy With CAPOX Versus Chemoradiation for Locally Advanced Rectal Cancer With Uninvolved Mesorectal Fascia (CONVERT): Initial Results of a Phase III Trial
7. High dose chemoradiotherapy increases chance of organ preservation with satisfactory functional outcome for rectal cancer
8. Comprehensive profiling of 1015 patients’ exomes reveals genomic-clinical associations in colorectal cancer
9. Inflammation promotes resistance to immune checkpoint inhibitors in high microsatellite instability colorectal cancer
10. Temporal Change in Treatment Patterns of Metastatic Colorectal Cancer and Its Association with Patient Survival: A Retrospective Cohort Study Based on an Intelligent Big-Data Platform
11. Total neoadjuvant treatment with long-course radiotherapy versus concurrent chemoradiotherapy in local advanced rectal cancer with high risk factors (TNTCRT): A multicenter, randomized, open-label, phase 3 trial.
12. Histopathological growth patterns correlate with the immunoscore in colorectal cancer liver metastasis patients after hepatectomy
13. Comparisons of screening strategies for identifying Lynch syndrome among patients with MLH1-deficient colorectal cancer
14. The watch-and-wait strategy versus surgical resection for rectal cancer patients with a clinical complete response after neoadjuvant chemoradiotherapy
15. Neoadjuvant chemoradiotherapy in patients with unresectable locally advanced sigmoid colon cancer: clinical feasibility and outcome
16. A fecal-based test for the detection of advanced adenoma and colorectal cancer: a case-control and screening cohort study
17. The degree of microsatellite instability predicts response to PD-1 blockade immunotherapy in mismatch repair-deficient/microsatellite instability-high colorectal cancers
18. Dickkopf-related protein 1, a new biomarker for local immune status and poor prognosis among patients with colorectal liver Oligometastases: a retrospective study
19. Update on Familial Adenomatous Polyposis-Associated Desmoid Tumors.
20. Screening and Management of Lynch Syndrome: The Chinese Experience.
21. Nonoperative Management of dMMR/MSI-H Colorectal Cancer following Neoadjuvant Immunotherapy: A Narrative Review.
22. The Immunoscore system predicts prognosis after liver metastasectomy in colorectal cancer liver metastases
23. Safety of intraoperative chemotherapy with 5-FU for colorectal cancer patients receiving curative resection: a randomized, multicenter, prospective, phase III IOCCRC trial (IOCCRC)
24. Patterns of recurrence in patients achieving pathologic complete response after neoadjuvant chemoradiotherapy for rectal cancer
25. Neoadjuvant Sandwich Treatment With Oxaliplatin and Capecitabine Administered Prior to, Concurrently With, and Following Radiation Therapy in Locally Advanced Rectal Cancer: A Prospective Phase 2 Trial
26. Neoadjuvant oxaliplatin and capecitabine combined with bevacizumab plus radiotherapy for locally advanced rectal cancer: results of a single-institute phase II study
27. The prognostic impact of preoperative blood monocyte count in pathological T3N0M0 rectal cancer without neoadjuvant chemoradiotherapy
28. Tailored selection of the interval between neoadjuvant chemoradiotherapy and surgery for locally advanced rectal cancer: analysis based on the pathologic stage or chemoradiation response
29. Simple measurements on diffusion-weighted MR imaging for assessment of complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer
30. Selective use of adjuvant chemotherapy for rectal cancer patients with ypN0
31. BCR-ABL tyrosine kinase inhibitors in the treatment of Philadelphia chromosome positive chronic myeloid leukemia: A review
32. Impact of ERβ and CD44 expression on the prognosis of patients with stage II colon cancer
33. Different effects of ERβ and TROP2 expression in Chinese patients with early-stage colon cancer
34. Elevated neutrophil to lymphocyte ratio predicts poor prognosis in nasopharyngeal carcinoma
35. Depth of Tumor Invasion Independently Predicts Lymph Node Metastasis in T2 Rectal Cancer
36. Elevated preoperative neutrophil to lymphocyte ratio predicts risk of recurrence following curative resection for stage IIA colon cancer
37. Evaluation of capecitabine and oxaliplatin administered prior to and then concomitant to radiotherapy in high risk locally advanced rectal cancer
38. Is early surveillance with CT scan necessary in patients with stage II/III colorectal cancer: A retrospective study
39. The total number of lymph nodes harvested from pathological T3N0 rectal cancer patients: Prognostic significance and potential indication for postoperative radiotherapy
40. Plasma Epstein-Barr Virus Dna Level Strongly Predicts Survival in Metastatic/Recurrent Nasopharyngeal Carcinoma Treated With Palliative Chemotherapy
41. A multivariate analysis of prognostic determinants for stages II and III colorectal cancer in 141 patients
42. Application of Molecular Profiling in Colorectal Cancer Surgery.
43. Beneficiaries of radical surgery among clinical complete responders to neoadjuvant chemoradiotherapy in rectal cancer.
44. Ex vivo localization and immunohistochemical detection of sentinel lymph node micrometastasis in patients with colorectal cancer can upgrade tumor staging
45. Low prevalence of mismatch repair deficiency in Chinese colorectal cancers: a multicenter study.
46. Germline mutational profile of Chinese patients under 70 years old with colorectal cancer.
47. PD-1 blockade in neoadjuvant setting of DNA mismatch repair-deficient/microsatellite instability-high colorectal cancer.
48. Phase III randomized, placebo‐controlled, double‐blind study of monosialotetrahexosylganglioside for the prevention of oxaliplatin‐induced peripheral neurotoxicity in stage II/III colorectal cancer.
49. Effect of Neoadjuvant Chemoradiotherapy with Capecitabine versus Fluorouracil for Locally Advanced Rectal Cancer: A Meta-Analysis
50. A frameshift mutation in exon 19 of MLH1 in a Chinese Lynch syndrome family: a pedigree study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.